Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001522000 | SCV001731449 | benign | Progressive myoclonic epilepsy type 9; Lipodystrophy, partial, acquired, susceptibility to | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001657747 | SCV001880974 | benign | not provided | 2021-06-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001657747 | SCV005313544 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000117495 | SCV000151713 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |